My data shows that on average people lose 9-14% on average when treated with classic weight loss drugs while the top 10% of my patients lose 21-29%
Two-thirds of the included patients had T2DM [99]
Timing guidelines for specific GLP-1 medications Each GLP-1 receptor agonist has its own pharmacokinetic personality
These medications are not suitable for everyone and may be contraindicated in patients with certain medical conditions including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy

Designs for Health Introduces Akkermansia Pro GLP-1 Probiotic to Advance Metabolic and Microbiome Health Support Designs for Health Introduces Akkermansia Pro GLP-1 Probiotic to Advance Metabolic and Microbiome Health Support PR Newswire PALM COAST, Fla., June 17, 2026 New probiotic and postbiotic blend targets microbiome health, metabolic balance, and healthy body composition through clinically studied ingredients* PALM COAST, Fla., June 17, 2026 /PRNewswire/ -- Designs for Health, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today announced the launch of Akkermansia Pro GLP-1 Probiotic, a groundbreaking once-daily probiotic and postbiotic formula that combines live Akkermansia muciniphila with the clinically studied BPL1 postbiotic to support the gutmetabolic connection, the body's natural GLP-1 production, and healthy weight management.* As research continues to explore the connection between the gut microbiome and metabolic health, emerging science suggests that specific keystone bacterial strains, those that are foundational to the gut microbiome, may play a vital role in supporting appetite regulation, blood sugar metabolism, gut barrier integrity, and overall metabolic resilience

mesohyal x-DNA INTRADERMAL MEDICAL SOLUTIONS Tratamento de administrao intradrmica para melhorar linhas de expresso dinmicas e do dano fotoinduzido